SCYNEXIS, Inc. Debt Instrument, Interest Rate, Stated Percentage
SCYNEXIS, Inc. (SCYX) had Debt Instrument, Interest Rate, Stated Percentage of 6.00% as of 2020-04-09, per its 10-K filed 2022-03-29.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2022-03-29
- 2020-04-09: Debt Instrument, Interest Rate, Stated Percentage 6.00%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2020-04-09 | 6.00% 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |